Submit Deal

BRISTOL MYERS SQUIBB COMPANY

HQ - Lawrence

Summary

Bristol Myers Squibb engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products.

Deals Overview

Total Deals39

Valued Deals33

Total Value£ 123.60 B

Avg. Deal Size£ 3.75 B

Market Context

Senior Management

Giovanni Caforio
Chairman and CEO
Charles Bancroft
CFO
David Elkins
CFO

Sort

giovanni caforio

Chairman and CEO at BRISTOL MYERS SQUIBB COMPANY

Manager

Deals

£ 107.23 B

Total Value

sandra leung

General Counsel at BRISTOL MYERS SQUIBB COMPANY

Manager

Deals

£ 86.86 B

Total Value

joseph campisi

General Counsel at BRISTOL MYERS SQUIBB COMPANY

Manager

Deals

£ 71.92 B

Total Value

christophe beauduin

Senior Counsel at BRISTOL MYERS SQUIBB COMPANY

Manager

Deal

£ 1.27 B

Total Value

charles bancroft

CFO at BRISTOL MYERS SQUIBB COMPANY

Manager

Deals

£ 82.82 B

Total Value

tim power

Investors Relations Director at BRISTOL MYERS SQUIBB COMPANY

Manager

Deals

£ 80.67 B

Total Value

paul biondi

Senior Vice President at BRISTOL MYERS SQUIBB COMPANY

Manager

Deals

£ 81.56 B

Total Value

nina goworek

Investors Relations Director at BRISTOL MYERS SQUIBB COMPANY

Manager

Deals

£ 10.01 B

Total Value

carrie l. fernandez

Communications Director at BRISTOL MYERS SQUIBB COMPANY

Manager

Deal

£ 70.66 B

Total Value

robert plenge

Senior Vice President, and Head of the Immunology, Cardiovascular and Fibrosis Thematic Research Center at BRISTOL MYERS SQUIBB COMPANY

Manager

Deal

£ 100 M

Total Value

rupert vessey

Vice President at BRISTOL MYERS SQUIBB COMPANY

Manager

Deal

n/a

Total Value

lou schmukler

President at BRISTOL MYERS SQUIBB COMPANY

Manager

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy